
Omalizumab for management of refractory urticaria: Experience of a tertiary care centre in Eastern India
Author(s) -
Shekhar Neema,
Manas Chatterjee
Publication year - 2018
Publication title -
indian journal of dermatology/indian journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.395
H-Index - 36
eISSN - 1998-3611
pISSN - 0019-5154
DOI - 10.4103/ijd.ijd_342_16
Subject(s) - omalizumab , medicine , refractory (planetary science) , chronic urticaria , tertiary care , retrospective cohort study , pediatrics , surgery , immunoglobulin e , antibody , immunology , physics , astrobiology
To study the effects of omalizumab in chronic spontaneous urticaria in Indian patients.